Understanding Kratom Alkaloids: Mitragynine 101
Key Takeaways
- Kratom contains 40+ identified alkaloids
- Mitragynine is most abundant at 1–2% of dried leaf weight
- 7-Hydroxymitragynine is a trace alkaloid (0.01–0.04%) in natural leaf
- Concentrated 7-OH products are the primary driver of recent regulation
- COA alkaloid panels are the only reliable way to verify what is in a product
Alkaloids: What They Are
Alkaloids are naturally occurring chemical compounds produced by plants, typically containing nitrogen atoms in their molecular structure. Many plant alkaloids have biological activity — caffeine in coffee, nicotine in tobacco, and morphine in opium poppies are well-known examples. Kratom (Mitragyna speciosa) produces its own unique set of alkaloids, with over 40 identified to date.
Mitragynine
Mitragynine is the most abundant alkaloid in kratom leaf, typically making up 1–2% of dried leaf material by weight (10–20 mg/g). It is the primary subject of pharmacological research into kratom and the main alkaloid quantified on Certificates of Analysis.
Research has characterized mitragynine as a partial agonist at mu-opioid receptors, meaning it interacts with the same receptor system as opioids but through a different binding mechanism and with a different pharmacological profile. Mitragynine is also reported to interact with adrenergic, serotonergic, and dopaminergic receptor systems, though research in these areas is still developing.
7-Hydroxymitragynine (7-OH)
7-Hydroxymitragynine is present in kratom leaf at trace concentrations — typically 0.01% to 0.04% by weight (0.1–0.4 mg/g). Despite its low natural concentration, 7-OH has received outsized regulatory attention because it is significantly more potent at mu-opioid receptors than mitragynine in preclinical studies.
The distinction between natural 7-OH in leaf and concentrated 7-OH products is critical. Products marketed as '7-OH' tablets or shots contain concentrations many times higher than what occurs in natural leaf — and these concentrated products are the primary driver of recent state bans. Understanding this distinction is important both for regulatory awareness and for reading COAs accurately.
Other Notable Alkaloids
| Alkaloid | Typical Abundance | Notes |
|---|---|---|
| Speciogynine | 6–7% of total alkaloids | Second most abundant; smooth muscle interactions in preclinical studies |
| Paynantheine | 5–9% of total alkaloids | Third most abundant; smooth muscle interactions studied |
| Speciociliatine | ~1% of total alkaloids | Stereoisomer of mitragynine; less studied |
| Mitraphylline | Trace | Also found in cat's claw; anti-inflammatory properties studied in vitro |
| Corynantheidine | Trace | Competitive opioid receptor antagonist in preclinical models |
Alkaloids on a COA
When reading a COA, the alkaloid panel tells you the actual chemical composition of your specific batch. Key things to look for:
Mitragynine percentage should fall within the typical 1–2% range for standard leaf powder. Values significantly above 2% may indicate an enhanced or extract product. The 7-OH percentage in natural leaf should be very low (0.01–0.04%). Values notably above this range in a product labeled as plain leaf may indicate enhancement or adulteration.
MIT45
AKA Certified • Triple Purification ProcessAlkaloid-tested products with published COAs
Shop MIT45 →Kratom Country
Lab Tested • Fresh Small-Batch SourcingAlkaloid-tested products with published COAs
Shop Kratom Country →Frequently Asked Questions
What is mitragynine?
Mitragynine is the most abundant alkaloid in kratom leaf, typically comprising 1–2% of dried leaf material. It is the primary alkaloid studied in kratom research and the main component measured in alkaloid quantification panels on COAs.
Why is 7-hydroxymitragynine controversial?
7-OH occurs naturally in trace amounts in kratom leaf (0.01–0.04%) but has become regulatory focus because concentrated 7-OH products at much higher levels have proliferated in the market. Many recent state bans target concentrated 7-OH specifically.
Disclaimer: KratomDeals.co is an independent comparison site. We may earn a commission when you purchase through our links at no additional cost to you. Kratom is not FDA-approved and is not intended to diagnose, treat, cure, or prevent any disease. Kratom is not legal in all U.S. states — please verify your local laws before ordering. These statements have not been evaluated by the Food and Drug Administration.